Published in

Oxford University Press, Journal of Antimicrobial Chemotherapy, 4(71), p. 1056-1062, 2015

DOI: 10.1093/jac/dkv427

Links

Tools

Export citation

Search in Google Scholar

Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

Journal article published in 2015 by Maria Yllescas, Yazdanpanah Yazdan, Patrick Yeni, David Zucman, Nikos Dedes, Geneviève Chěne, Clotilde Allavena, Brigitte Autran, Andrea Antinori, S. Lambert-Niclot, Raffaella Bucciardini, Stefano Vella, Andrzej Horban, Jose Arribas, Abdel G. Babiker and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO